Real World Study on First Line Crizotinib in ROS1 Rearranged Advanced Non-squamous Non-small Cell Lung Cancer
Clinical trial NCT03646994 · UNKNOWN
Trial details
- NCT number
- NCT03646994
- Sponsor
- Hunan Province Tumor Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2018-08-01
- Primary completion
- 2024-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.